Your browser is no longer supported. Please, upgrade your browser.
Settings
ETON Eton Pharmaceuticals, Inc. daily Stock Chart
ETON [NASD]
Eton Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.15 Insider Own33.17% Shs Outstand21.01M Perf Week19.91%
Market Cap174.18M Forward P/E- EPS next Y-0.78 Insider Trans6.10% Shs Float11.37M Perf Month-8.23%
Income-21.40M PEG- EPS next Q-0.25 Inst Own32.60% Short Float7.98% Perf Quarter42.78%
Sales0.60M P/S290.30 EPS this Y51.20% Inst Trans0.06% Short Ratio1.56 Perf Half Y97.39%
Book/sh0.33 P/B25.18 EPS next Y33.30% ROA-137.50% Target Price- Perf Year37.13%
Cash/sh0.49 P/C16.91 EPS next 5Y- ROE-211.50% 52W Range2.50 - 9.12 Perf YTD15.42%
Dividend- P/FCF- EPS past 5Y- ROI-123.20% 52W High-13.16% Beta-
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin77.50% 52W Low216.80% ATR0.59
Employees5 Current Ratio4.70 Sales Q/Q- Oper. Margin- RSI (14)55.79 Volatility6.61% 7.20%
OptionableNo Debt/Eq0.71 EPS Q/Q-22.90% Profit Margin- Rel Volume0.59 Prev Close8.31
ShortableYes LT Debt/Eq0.69 Earnings- Payout- Avg Volume581.50K Price7.92
Recom2.00 SMA204.50% SMA505.70% SMA20033.00% Volume341,579 Change-4.69%
Sep-20-19Initiated B. Riley FBR Buy $13.50
Jun-10-19Initiated H.C. Wainwright Buy $15
Oct-16-20 04:05PM  
Oct-15-20 08:30AM  
Oct-14-20 08:30AM  
Oct-13-20 04:01PM  
07:08AM  
Oct-08-20 08:00AM  
Oct-06-20 04:05PM  
Sep-30-20 06:57PM  
10:31AM  
07:45AM  
Sep-29-20 06:50PM  
Sep-25-20 11:24AM  
08:00AM  
Sep-17-20 10:11AM  
Sep-16-20 09:00AM  
Sep-01-20 06:05PM  
Aug-31-20 08:00AM  
Aug-12-20 09:45AM  
08:45AM  
08:30AM  
Aug-11-20 09:00AM  
Aug-04-20 04:10PM  
07:57AM  
Jul-30-20 08:00AM  
Jul-27-20 07:30AM  
Jun-04-20 06:16PM  
May-14-20 05:25PM  
04:02PM  
May-07-20 12:30PM  
08:00AM  
May-06-20 04:30PM  
07:15AM  
May-04-20 08:00AM  
Apr-28-20 12:33PM  
Apr-16-20 12:13PM  
Mar-30-20 09:56AM  
Mar-27-20 07:00AM  
Mar-26-20 12:00PM  
Mar-17-20 08:00AM  
Mar-06-20 08:49AM  
Mar-05-20 06:25PM  
04:02PM  
02:30PM  
Feb-27-20 04:10PM  
Feb-21-20 07:08AM  
Feb-19-20 08:00AM  
Feb-13-20 04:05PM  
Jan-21-20 07:00AM  
Dec-31-19 12:46PM  
Dec-22-19 01:23PM  
Dec-02-19 07:30AM  
Nov-14-19 04:01PM  
Nov-13-19 04:55PM  
Nov-12-19 08:27AM  
Nov-06-19 04:05PM  
Oct-22-19 07:00AM  
Sep-19-19 11:53AM  
Sep-13-19 09:00AM  
Sep-03-19 04:01PM  
Aug-19-19 05:55PM  
07:00AM  
Aug-14-19 09:10AM  
Aug-13-19 09:50AM  
Aug-12-19 08:37AM  
Aug-07-19 11:20AM  
Aug-06-19 07:01AM  
Aug-02-19 09:06AM  
07:30AM  
Aug-01-19 08:01AM  
Jul-30-19 08:01AM  
Jul-25-19 07:30AM  
Jul-16-19 08:17AM  
Jul-15-19 02:07PM  
Jul-12-19 04:24PM  
04:01PM  
Jun-25-19 03:17PM  
Jun-19-19 08:25AM  
Jun-18-19 10:25AM  
Jun-14-19 08:47AM  
Jun-13-19 04:01PM  
May-23-19 03:09PM  
May-15-19 04:01PM  
May-07-19 04:05PM  
08:05AM  
Apr-30-19 04:30PM  
Mar-25-19 08:01AM  
Mar-14-19 08:00AM  
Feb-21-19 03:34PM  
08:00AM  
Feb-20-19 07:34AM  
Feb-19-19 07:00AM  
Feb-11-19 08:01AM  
Jan-25-19 07:38AM  
Jan-24-19 04:10PM  
Dec-20-18 06:30AM  
Nov-16-18 07:30AM  
Nov-12-18 04:52PM  
Oct-28-18 10:53AM  
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Opaleye Management Inc.10% OwnerOct 16Buy7.00400,0002,800,0003,885,000Oct 16 09:30 PM